21 results on '"Jeannet, P Y"'
Search Results
2. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy
- Author
-
Bernert, G., Knipp, F., Buyse, G.M., Goemans, N., van den Hauwe, M., Voit, T., Doppler, V., Gidaro, T., Cuisset, J.-M., Coopman, S., Schara, U., Lutz, S., Kirschner, J., Borell, S., Will, M., D'Angelo, M.G., Brighina, E., Gandossini, S., Gorni, K., Falcier, E., Politano, L., D'Ambrosio, P., Taglia, A., Verschuuren, J.J.G.M., Straathof, C.S.M., Vílchez Padilla, J.J., Muelas Gómez, N., Sejersen, T., Hovmöller, M., Jeannet, P.-Y., Bloetzer, C., Iannaccone, S., Castro, D., Tennekoon, G., Finkel, R., Bönnemann, C., McDonald, C., Henricson, E., Joyce, N., Apkon, S., Richardson, R.C., McDonald, Craig M., Meier, Thomas, Voit, Thomas, Schara, Ulrike, Straathof, Chiara S.M., D'Angelo, M. Grazia, Bernert, Günther, Cuisset, Jean-Marie, Finkel, Richard S., Goemans, Nathalie, Rummey, Christian, Leinonen, Mika, Spagnolo, Paolo, and Buyse, Gunnar M.
- Published
- 2016
- Full Text
- View/download PDF
3. The role of posterior fossa decompression in acute cerebellitis
- Author
-
de Ribaupierre, S., Meagher-Villemure, K., Villemure, J. G., Cotting, J., Jeannet, P. Y., Porchet, F., Roulet, E., and Bloch, J.
- Published
- 2005
- Full Text
- View/download PDF
4. Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy?
- Author
-
Krahn, M, Goicoechea, M, Hanisch, F, Groen, E, Bartoli, M, Pécheux, C, Garcia-Bragado, F, Leturcq, F, Jeannet, P-Y, Lobrinus, J A, Jacquemont, S, Strober, J, Urtizberea, J A, Saenz, A, Bushby, K, Lévy, N, and de Munain, A Lopez
- Published
- 2011
- Full Text
- View/download PDF
5. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)
- Author
-
Lobrinus, J.A., Schorderet, D.F., Payot, M., Jeanrenaud, X., Bottani, A., Superti-Furga, A., Schlaepfer, J., Fromer, M., and Jeannet, P.-Y.
- Published
- 2005
- Full Text
- View/download PDF
6. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy
- Author
-
Buyse, G.M., Voit, Thomas, Schara, Ulrike, Straathof, C.S.M., D’Angelo, M.G., Bernert, G., Cuisset, J.-M., Finkel, Richard S., Goemans, N., Rummey, Christian, Leinonen, Mika, Mayer, Oscar H., Spagnolo, Paolo, Meier, Thomas, McDonald, Craig M., Knipp, F., Van den Hauwe, M., Doppler, V., Gidaro, T., Coopman, S., Lutz, S., Kirschner, J., Borell, S., Will, M., Brighina, E., Gandossini, S., Gorni, K., Falcier, E., Politano, L., D’Ambrosio, P., Taglia, A., Verschuuren, J.J.G.M., Vílchez Padilla, J.J., Muelas Gómez, N., Sejersen, T., Hovmöller, M., Jeannet, P.-Y., Bloetzer, C., Iannaccone, S., Castro, D., Tennekoon, G., Bönnemann, C., Henricson, E., Joyce, N., Apkon, S., Richardson, R.C., and Van den Hauwe, M
- Subjects
0301 basic medicine ,Male ,Ubiquinone ,Duchenne muscular dystrophy ,Medizin ,Pediatrics ,Antioxidants ,Pulmonary function testing ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,law ,respiratory function ,Idebenone ,Respiratory function ,Lung volumes ,Muscular Dystrophy ,Child ,Genetics (clinical) ,Respiration ,Perinatology and Child Health ,Inspiratory flow ,Pediatrics, Perinatology and Child Health ,Pulmonary and Respiratory Medicine ,3. Good health ,Respiratory Function Tests ,Treatment Outcome ,Neurology ,Cardiology ,Inspiratory Reserve Volume ,inspiratory flow ,Female ,Original Article ,medicine.drug ,medicine.medical_specialty ,Adolescent ,Outcomes ,Placebo ,03 medical and health sciences ,FEV1/FVC ratio ,Internal medicine ,medicine ,Humans ,Treatment effect ,In patient ,business.industry ,Original Articles ,idebenone ,Muscular Dystrophy, Duchenne ,Duchenne ,medicine.disease ,Surgery ,030104 developmental biology ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Assessment of dynamic inspiratory function may provide valuable information about the degree and progression of pulmonary involvement in patients with Duchenne muscular dystrophy (DMD). The aims of this study were to characterize inspiratory function and to assess the efficacy of idebenone on this pulmonary function outcome in a large and well-characterized cohort of 10-18 year-old DMD patients not taking glucocorticoid steroids (GCs) enrolled in the phase 3 randomized controlled DELOS trial. We evaluated the effect of idebenone on the highest flow generated during an inspiratory FVC maneuver (maximum inspiratory flow; V'I,max(FVC)) and the ratio between the largest inspiratory flow during tidal breathing (tidal inspiratory flow; V'I,max(t)) and the V'I,max(FVC). The fraction of the maximum flow that is not used during tidal breathing has been termed inspiratory flow reserve (IFR). DMD patients in both treatment groups of DELOS (idebenone, n = 31; placebo: n = 33) had comparable and abnormally low V'I,max(FVC) at baseline. During the study period, V'I,max(FVC) further declined by -0.29 L/sec in patients on placebo (95%CI: -0.51, -0.08; P = 0.008 at week 52), whereas it remained stable in patients on idebenone (change from baseline to week 52: 0.01 L/sec; 95%CI: -0.22, 0.24; P = 0.950). The between-group difference favoring idebenone was 0.27 L/sec (P = 0.043) at week 26 and 0.30 L/sec (P = 0.061) at week 52. In addition, during the study period, IFR improved by 2.8% in patients receiving idebenone and worsened by -3.0% among patients on placebo (between-group difference 5.8% at week 52; P = 0.040). Although the clinical interpretation of these data is currently limited due to the scarcity of routine clinical practice experience with dynamic inspiratory function outcomes in DMD, these findings from a randomized controlled study nevertheless suggest that idebenone preserved inspiratory muscle function as assessed by V'I,max(FVC) and IFR in patients with DMD. Pediatr Pulmonol. © 2016 The Authors. Pediatric Pulmonology Published by Wiley Periodicals, Inc. ispartof: Pediatric Pulmonology vol:52 issue:4 pages:508-515 ispartof: location:United States status: published
- Published
- 2016
7. The TREAT-NMD DMD global database: Analysis of more than 7,000 duchenne muscular dystrophy mutations
- Author
-
Bladen, C.L. Salgado, D. Monges, S. Foncuberta, M.E. Kekou, K. Kosma, K. Dawkins, H. Lamont, L. Roy, A.J. Chamova, T. Guergueltcheva, V. Chan, S. Korngut, L. Campbell, C. Dai, Y. Wang, J. Barišić, N. Brabec, P. Lahdetie, J. Walter, M.C. Schreiber-Katz, O. Karcagi, V. Garami, M. Viswanathan, V. Bayat, F. Buccella, F. Kimura, E. Koeks, Z. van den Bergen, J.C. Rodrigues, M. Roxburgh, R. Lusakowska, A. Kostera-Pruszczyk, A. Zimowski, J. Santos, R. Neagu, E. Artemieva, S. Rasic, V.M. Vojinovic, D. Posada, M. Bloetzer, C. Jeannet, P.-Y. Joncourt, F. Díaz-Manera, J. Gallardo, E. Karaduman, A.A. Topaloğlu, H. El Sherif, R. Stringer, A. Shatillo, A.V. Martin, A.S. Peay, H.L. Bellgard, M.I. Kirschner, J. Flanigan, K.M. Straub, V. Bushby, K. Verschuuren, J. Aartsma-Rus, A. Béroud, C. Lochmüller, H.
- Abstract
Analyzing the type and frequency of patient-specific mutations that give rise to Duchenne muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research, trial planning, and improved clinical care. Locus-specific databases allow for the collection, organization, storage, and analysis of genetic variants of disease. Here, we describe the development and analysis of the TREAT-NMD DMD Global database (http://umd.be/TREAT_DMD/). We analyzed genetic data for 7,149 DMD mutations held within the database. A total of 5,682 large mutations were observed (80% of total mutations), of which 4,894 (86%) were deletions (1 exon or larger) and 784 (14%) were duplications (1 exon or larger). There were 1,445 small mutations (smaller than 1 exon, 20% of all mutations), of which 358 (25%) were small deletions and 132 (9%) small insertions and 199 (14%) affected the splice sites. Point mutations totalled 756 (52% of small mutations) with 726 (50%) nonsense mutations and 30 (2%) missense mutations. Finally, 22 (0.3%) mid-intronic mutations were observed. In addition, mutations were identified within the database that would potentially benefit from novel genetic therapies for DMD including stop codon read-through therapies (10% of total mutations) and exon skipping therapy (80% of deletions and 55% of total mutations). © 2015 The Authors.
- Published
- 2015
8. An international prospective, longitudinal study of the natural history and functional status of patients with myotubular myopathy
- Author
-
Annoussamy, M., Landy, H., Ramsdell, D., Nelken, M., Muntoni, F., Bonnemann, C., Bharucha, D., Dowling, J. J., Amburgey, K., Lilien, C., Ollivier, G., Laporte, J., Biancalana, V., Schara, Ulrike, Cuisset, J. M., DAmico, A., Deconinck, N., Jeannet, P. Y., Klein, A., Fluss, J., Mayer, M., Seferian, A. M., Le Moing, A. G., Gidaro, T., Hogrel, J. Y., Mingozzi, F., Buj-Bello, A., Voit, Thomas, and Servais, L.
- Subjects
Medizin - Published
- 2014
9. Enhanced excitation coupled Ca2+ entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with Central core disease
- Author
-
Treves, Susan Nella, Jeannet, P. Y., Vukcevic, M., Levano, S., Girard, T., Urwyler, A., Fischer, D., Voit, T., Jungbluth, H., Lillis, S., Muntoni, F., Quinlivan, R., Sarkozy, A., Bushby, K., and Zorzato, Francesco
- Subjects
calcium ,Ryanodine receptor ,excitation-coupled calcium entry ,Central Core Disease ,mutations ,TIRF microscopy - Published
- 2010
10. Non-traumatic spinal cord ischaemia in childhood – Clinical manifestation, neuroimaging and outcome.
- Author
-
Stettler, Sonja, El-Koussy, Marwan, Ritter, Barbara, Boltshauser, Eugen, Jeannet, Pierre-Y., Kolditz, Petra, Meyer-Heim, Andreas, and Steinlin, Maja
- Subjects
SPINAL cord diseases ,ISCHEMIA ,JUVENILE diseases ,CLINICAL trials ,BRAIN imaging ,HEALTH outcome assessment ,MEDICAL informatics ,QUALITY of life - Abstract
Abstract: Background: Spinal cord ischaemia is rare in childhood and information on clinical presentation and outcome is scarce. Methods: This is a retrospective analysis of eight patients and 75 additional cases from the literature. Data search included: patient''s age, primary manifestation, risk factors, neuroimaging and outcome. Results: Five female and three male patients gave consent to participate. Mean age was 12.5 years (10–15 years). Six patients presented with paraplegia; this was preceded by pain in four. Brown Sequard syndrome and quadriparesis were the two others'' presenting condition. Sensation levels were thoracolumbar in seven cases. Bladder dysfunction only or bladder and bowel dysfunction were reported in eight and five patients respectively. Time to maximal symptom manifestation was <12 h in 7/8. Risk factors included surgery, minor trauma, recent infection, and thrombophilia. Mean follow-up was 3.3 years (0.25–6.3 years). Three patients remained wheelchair-dependent and three patients were ambulatory without aid. Bladder function recovered fully in five children. Most affected aspects of quality of life were physical and mental well-being and self-perception. T2-weighted-MR images showed pencil-like hyperintensity (8/8) in sagittal and H-shaped or snake-eyes-like lesion (6/8) in axial views. Analyses of all 83 patients were in congruence with the above results of the study group. Conclusion: Spinal cord ischaemia in childhood presenting with pain, paraplegia, and bladder dysfunction has high morbidity concerning motor problems and quality of life. Acute arterial ischaemic event in children seems similar to adult events with respect to clinical presentation and, surprisingly, also in outcome. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
11. Clinical and histologic findings in autosomal centronuclear myopathy.
- Author
-
Jeannet, P-Y, Bassez, G, Eymard, B, Laforêt, P, Urtizberea, J A, Rouche, A, Guicheney, P, Fardeau, M, and Romero, N B
- Published
- 2004
- Full Text
- View/download PDF
12. Craniofacial and cutaneous findings expand the phenotype of hereditary neuralgic amyotrophy.
- Author
-
Jeannet, P Y, Watts, G D, Bird, T D, and Chance, P F
- Published
- 2001
- Full Text
- View/download PDF
13. Local variability in respiratory syncytial virus disease severity.
- Author
-
Brandenburg, Afke H., Jeannet, Pierre-Yves, Steensel-Moll, Henriette A. v, Ott, Alewijn, Rothbarth, Philip H., Wunderli, Werner, Suter, Susanne, Neijens, Herman J., Osterhaus, Albert D. M. E., Siegrist, Claire-Anne, Brandenburg, A H, Jeannet, P Y, Steensel-Moll, H A, Ott, A, Rothbarth, P H, Wunderli, W, Suter, S, Neijens, H J, Osterhaus, A D, and Siegrist, C A
- Abstract
Respiratory syncytial virus (RSV) lower respiratory tract infections are considered to be a serious disease in centres such as the Sophia Children's Hospital (Rotterdam, the Netherlands), but as more benign infections in others such as the Geneva Children's Hospital (Switzerland). To assess the clinical severity of RSV infections at the two sites, 151 infants primarily admitted with a virologically confirmed RSV infection were studied prospectively (1994-5) and retrospectively (1993-4) (55 infants in Geneva and 96 in Rotterdam). Parameters of RSV morbidity which were more severe in Rotterdam during the two winter seasons were apnoea (1.8 v 23.9%), the rate of admission to the intensive care unit (3.6 v 28.1%), mechanical ventilation (0 v 7.3%), and length of stay in hospital (6.8 v 9.1 days). In Geneva higher respiratory rates (59.2 v 51.2), more wheezing (65.5 v 28.8%), and more retractions (81.8 v 63.3%) were recorded. Fewer infants younger than 4 months (54.9 v 68.7%), but more breast fed infants (94.1 v 38.5%), were admitted in Geneva, although the morbidity parameters remained different after correction for these two variables in multivariate analyses. Thus unidentified local factors influence the pattern and severity of RSV infection and may affect the results of multicentre prophylactic and therapeutic studies. [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
14. P296 GLUT1 deficiency with paroxysmal gait, movement and behaviour disorder and mild transient epilepsy
- Author
-
Jeannet, P.-Y., Bonafé, L., and Roulet-Perez, E.
- Published
- 2009
- Full Text
- View/download PDF
15. Atypical Presentation of Prader-Willi Syndrome with Cerebral Venous Thrombosis: Association or Fortuity?
- Author
-
Beretta, L., Hauschild, M., Jeannet, P.-Y., Addor, M.-C., Maeder, P., and Truttmann, A. C.
- Subjects
PEDIATRIC neurology ,JUVENILE diseases ,CEREBRAL embolism & thrombosis ,PRADER-Willi syndrome ,HUMAN chromosome 15 abnormalities ,INTELLECTUAL disabilities ,CLINICAL trials - Abstract
A newborn female born at term was admitted at 28 hours for seizures and generalized hypotonia. Cerebral ultrasound showed a right temporal echogenic lesion confirmed on MRI and thought to be secondary to thrombosis of the vein of Labbé. The EEG showed epileptic discharges over the right temporal region. Extensive thrombotic studies revealed a transiently decreased PTT consistent with a prothrombotic state. The hypotonia did not resolve after the acute phase as expected, raising the possibility of another underlying cause. Because of a peculiar phenotype with almond-shaped eyes and bitemporal depression, Prader-Willi syndrome (PWS) was suspected. Methylation analysis confirmed PWS, FISH analysis excluded a deletion in 15q11-q13, maternal uniparental disomy (UPD) was confirmed. To our knowledge, this is the first report of the association of a neonatal venous thrombosis and a PW Syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
16. 120 Intranasal or sublingual midazolam for treating acute seizures in children at home
- Author
-
Jutzi, A., Jeannet, P.-Y., Roulet, E., and Deonna, T.
- Published
- 1999
- Full Text
- View/download PDF
17. Characterization of pulmonary function in 10–18 year old patients with Duchenne muscular dystrophy
- Author
-
Ulrike Schara, Diana Castro, T. Gidaro, S. Lutz, Ksenija Gorni, Janbernd Kirschner, Antonella Taglia, V. Doppler, F. Knipp, Christian Rummey, Jan J.G.M. Verschuuren, Thomas Meier, Gihan Tennekoon, J.J. Vílchez Padilla, E. Falcier, Luisa Politano, Craig M. McDonald, Chiara S. M. Straathof, S. Borell, S. Coopman, Matthew J. Will, Pierre-Yves Jeannet, Nathalie Goemans, Paolo Spagnolo, Jean-Marie Cuisset, Carsten G. Bönnemann, R.C. Richardson, G. Bernert, Thomas Sejersen, N. Muelas Gómez, Maria Grazia D'Angelo, Erika Brighina, Thomas Voit, S. Gandossini, Mika Leinonen, Susan T. Iannaccone, Oscar H. Mayer, Gunnar M. Buyse, Clemens Bloetzer, M. van den Hauwe, Susan D. Apkon, Richard S. Finkel, G. Buyse, P. D’Ambrosio, Erik K Henricson, Nanette C. Joyce, M. Hovmöller, Van den Hauwe, M, Meier, Thoma, Rummey, Christian, Leinonen, Mika, Spagnolo, Paolo, Mayer, Oscar H., Buyse, Gunnar M., Bernert, G., Knipp, F., Buyse, G. M., Goemans, N., Van den Hauwe, M., Voit, T., Doppler, V., Gidaro, T., Cuisset, J. -. M., Coopman, S., Schara, U., Lutz, S., Kirschner, J., Borell, S., Will, M., D'Angelo, M. G., Brighina, E., Gandossini, S., Gorni, K., Falcier, E., Politano, L., D'Ambrosio, P., Taglia, A., Verschuuren, J. J. G. M., Straathof, C. S. M., VÃlchez Padilla, J. J., Muelas Gómez, N., Sejersen, T., Hovmã¶ller, M., Jeannet, P. -. Y., Bloetzer, C., Iannaccone, S., Castro, D., Tennekoon, G., Finkel, R., Bã¶nnemann, C., Mcdonald, C., Henricson, E., Joyce, N., Apkon, S., and Richardson, R. C.
- Subjects
Duchenne muscular dystrophy ,medicine.medical_specialty ,Vital capacity ,Adolescent ,peak expiratory flow ,Respiratory Tract Diseases ,Medizin ,Clinical Neurology ,Pulmonary insufficiency ,Placebo group ,Pediatrics ,Pulmonary function testing ,03 medical and health sciences ,FEV1/FVC ratio ,0302 clinical medicine ,forced vital capacity ,Internal medicine ,medicine ,Humans ,In patient ,Genetics(clinical) ,Pediatrics, Perinatology, and Child Health ,Longitudinal Studies ,Muscular Dystrophy ,Child ,Genetics (clinical) ,Old patients ,business.industry ,pulmonary function ,respiratory system ,Perinatology and Child Health ,medicine.disease ,Duchenne ,Cross-Sectional Studies ,Muscular Dystrophy, Duchenne ,Respiratory Function Tests ,Pediatrics, Perinatology and Child Health ,Neurology ,Neurology (clinical) ,Surgery ,respiratory tract diseases ,030228 respiratory system ,Cardiology ,business ,030217 neurology & neurosurgery ,circulatory and respiratory physiology - Abstract
Pulmonary function loss in patients with Duchenne muscular dystrophy (DMD) is progressive and leads to pulmonary insufficiency. The purpose of this study in 10-18 year old patients with DMD is the assessment of the inter-correlation between pulmonary function tests (PFTs), their reliability and the association with the general disease stage measured by the Brooke score. Dynamic PFTs (peak expiratory flow [PEF], forced vital capacity [FVC], forced expiratory volume in one second [FEV1]) and maximum static airway pressures (MIP, MEP) were prospectively collected from 64 DMD patients enrolled in the DELOS trial (ClinicalTrials.gov, number NCT01027884). Baseline PEF percent predicted (PEF%p) was
- Published
- 2017
18. Cerebellar cleft: confirmation of the neuroimaging pattern.
- Author
-
Poretti A, Huisman TA, Cowan FM, Del Giudice E, Jeannet PY, Prayer D, Rutherford MA, du Plessis AJ, Limperopoulos C, and Boltshauser E
- Subjects
- Adolescent, Cerebellar Diseases complications, Cerebellum growth & development, Child, Child, Preschool, Cognition Disorders etiology, Female, Follow-Up Studies, Humans, Infant, Male, Cerebellar Diseases diagnosis, Cerebellum abnormalities, Dilatation, Pathologic diagnosis, Magnetic Resonance Imaging methods
- Abstract
We recently described the neuroimaging and clinical findings in 6 children with cerebellar clefts and proposed that they result from disruptive changes following prenatal cerebellar hemorrhage. We now report an additional series of 9 patients analyzing the clinical and neuroimaging findings. The clefts were located in the left cerebellar hemisphere in 5 cases, in the right in 3, and bilaterally in one child who had bilateral cerebellar hemorrhages as a preterm infant at 30 weeks gestation. In one patient born at 24 weeks of gestation a unilateral cerebellar hemorrhage has been found at the age of 4 months. Other findings included disordered alignment of the folia and fissures, an irregular gray/white matter junction, and abnormal arborization of the white matter in all cases. Supratentorial abnormalities were found in 4 cases. All but 2 patients were born at term. We confirm the distinct neuroimaging pattern of cerebellar clefts. Considering the documented fetal cerebellar hemorrhage in our first series, we postulate that cerebellar clefts usually represent residual disruptive changes after a prenatal cerebellar hemorrhage. Exceptionally, as now documented in 2 patients, cerebellar clefts can be found after neonatal cerebellar hemorrhages in preterm infants. The short-term outcome in these children was variable., ((c) Georg Thieme Verlag KG Stuttgart . New York.)
- Published
- 2009
- Full Text
- View/download PDF
19. Autosomal dominant nemaline myopathy: a new phenotype unlinked to previously known genetic loci.
- Author
-
Jeannet PY, Mittaz L, Dunand M, Lobrinus JA, Bonafe L, and Kuntzer T
- Subjects
- Female, Humans, Male, Muscle Weakness etiology, Muscle, Skeletal pathology, Muscle, Skeletal ultrastructure, Phenotype, Family Health, Myopathies, Nemaline genetics, Myopathies, Nemaline pathology, Myopathies, Nemaline physiopathology, Pedigree
- Abstract
We report a large family with a mild form of autosomal dominant nemaline myopathy and a new phenotype. Onset of symptoms was in infancy with hypotonia and motor delay. Weakness involved neck flexors, abdominal and proximal limb muscles. There was no bulbar, respiratory or foot dorsiflexion weakness and no slowness in movement. Patients had remarkably good physical endurance and no limitation in daily activities, but were slow runners since childhood. Nemaline rods were seen in less than 5% of muscle fibres. No linkage to the five known nemaline myopathy genes (alpha-tropomyosin-3, nebulin, alpha-actin, troponin T1 and beta-tropomyosin), to the ryanodine receptor gene (associated with core-rod myopathy) or to the 15q21-23 locus was found.
- Published
- 2007
- Full Text
- View/download PDF
20. Hirayama disease associated with a severe rhythmic movement disorder involving neck flexions.
- Author
-
Jeannet PY, Kuntzer T, Deonna T, and Roulet-Perez E
- Subjects
- Child, Disease Progression, Female, Hand innervation, Hand pathology, Head Movements physiology, Humans, Magnetic Resonance Imaging, Movement Disorders complications, Movement Disorders diagnosis, Muscular Atrophy etiology, Muscular Atrophy pathology, Periodicity, Peripheral Nerves physiopathology, Sleep-Wake Transition Disorders complications, Sleep-Wake Transition Disorders diagnosis, Spinal Cord Diseases complications, Spinal Cord Injuries etiology, Spinal Cord Injuries pathology, Spinal Cord Injuries physiopathology, Spinal Nerve Roots injuries, Spinal Nerve Roots pathology, Spinal Nerve Roots physiopathology, Hand physiopathology, Movement Disorders physiopathology, Muscular Atrophy physiopathology, Neck Muscles physiopathology, Sleep-Wake Transition Disorders physiopathology, Spinal Cord Diseases physiopathology
- Published
- 2005
- Full Text
- View/download PDF
21. Home and hospital treatment of acute seizures in children with nasal midazolam.
- Author
-
Jeannet PY, Roulet E, Maeder-Ingvar M, Gehri M, Jutzi A, and Deonna T
- Subjects
- Acute Disease, Administration, Rectal, Adolescent, Anticonvulsants adverse effects, Child, Child, Preschool, Diazepam administration & dosage, Diazepam adverse effects, Electroencephalography drug effects, Epilepsy etiology, Female, Humans, Hypnotics and Sedatives adverse effects, Infant, Infant, Newborn, Male, Midazolam adverse effects, Treatment Outcome, Anticonvulsants administration & dosage, Epilepsy drug therapy, Home Nursing, Hospitalization, Hypnotics and Sedatives administration & dosage, Midazolam administration & dosage
- Abstract
Rectal diazepam is widely used in the treatment of acute seizures in children but has some disadvantages. Nasal/sublingual midazolam administration has been recently investigated for this purpose but never at home or in a general paediatric hospital. The aim of this open study was to determine the efficacy, the tolerance and the applicability of nasal midazolam during acute seizures in children both in hospital and at home. We included known epileptic children for treatment at home and all children with acute seizures in the hospital. In all, 26 children were enrolled, 11 at home and 17 in the hospital (including two treated in both locations); only one had simple febrile seizure. They had a total of 125 seizures; 122 seizures (98%) stopped within 10 minutes (average 3.6 minutes). Two patients in the hospital did not respond and in three, seizures recurred within 3 hours. None had serious adverse effects. Parents had no difficulties administering the drug at home. Most of those who were using rectal diazepam found that nasal midazolam was easier to use and that postictal recovery was faster. Among 15 children who received the drug under electroencephalogram monitoring (six without clinical seizures), the paroxysmal activity disappeared in ten and decreased in three. Nasal midazolam is efficient in the treatment of acute seizures. It appears to be safe and most useful outside the hospital in severe epilepsies, particularly in older children because it is easy for parents to use. These data should be confirmed in a larger sample of children. Its usefulness in febrile convulsions also remains to be evaluated., (Copyright 1999 European Paediatric Neurology Society.)
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.